182 related articles for article (PubMed ID: 28197634)
41. Expression of long non-coding RNA SFTA1P and its function in non-small cell lung cancer.
Du D; Shen X; Zhang Y; Yin L; Pu Y; Liang G
Pathol Res Pract; 2020 Sep; 216(9):153049. PubMed ID: 32825934
[TBL] [Abstract][Full Text] [Related]
42. SIRT3 regulates cell proliferation and apoptosis related to energy metabolism in non-small cell lung cancer cells through deacetylation of NMNAT2.
Li H; Feng Z; Wu W; Li J; Zhang J; Xia T
Int J Oncol; 2013 Nov; 43(5):1420-30. PubMed ID: 24042441
[TBL] [Abstract][Full Text] [Related]
43. Role of miR-497 in VEGF-A-mediated cancer cell growth and invasion in non-small cell lung cancer.
Gu A; Lu J; Wang W; Shi C; Han B; Yao M
Int J Biochem Cell Biol; 2016 Jan; 70():118-25. PubMed ID: 26485685
[TBL] [Abstract][Full Text] [Related]
44. MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC.
Chen W; Wang J; Liu S; Wang S; Cheng Y; Zhou W; Duan C; Zhang C
J Exp Clin Cancer Res; 2016 May; 35():76. PubMed ID: 27164951
[TBL] [Abstract][Full Text] [Related]
45. MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC).
Zhang JG; Wang JJ; Zhao F; Liu Q; Jiang K; Yang GH
Clin Chim Acta; 2010 Jun; 411(11-12):846-52. PubMed ID: 20223231
[TBL] [Abstract][Full Text] [Related]
46. CRIF1 promotes the progression of non-small-cell lung cancer by SIRT3- mediated deacetylation of PYCR1.
Wang Q; Xie Z; Li C; Xu C; Ding C; Ju S; Chen J; Cui Z; Chen C; Gu B; Wei T; Zhao J
J Mol Histol; 2022 Aug; 53(4):657-667. PubMed ID: 35716330
[TBL] [Abstract][Full Text] [Related]
47. KLHL38 involvement in non-small cell lung cancer progression via activation of the Akt signaling pathway.
Xu Y; Wang C; Jiang X; Zhang Y; Su H; Jiang J; Ren H; Qiu X
Cell Death Dis; 2021 May; 12(6):556. PubMed ID: 34050138
[TBL] [Abstract][Full Text] [Related]
48. EZH2 promotes tumor progression via regulating VEGF-A/AKT signaling in non-small cell lung cancer.
Geng J; Li X; Zhou Z; Wu CL; Dai M; Bai X
Cancer Lett; 2015 Apr; 359(2):275-87. PubMed ID: 25633838
[TBL] [Abstract][Full Text] [Related]
49. CD147-CD98hc complex contributes to poor prognosis of non-small cell lung cancer patients through promoting cell proliferation via the PI3K/Akt signaling pathway.
Fei F; Li X; Xu L; Li D; Zhang Z; Guo X; Yang H; Chen Z; Xing J
Ann Surg Oncol; 2014 Dec; 21(13):4359-68. PubMed ID: 25084765
[TBL] [Abstract][Full Text] [Related]
50. MKP1 repression is required for the chemosensitizing effects of NF-kappaB and PI3K inhibitors to cisplatin in non-small cell lung cancer.
Cortes-Sempere M; Chattopadhyay S; Rovira A; Rodriguez-Fanjul V; Belda-Iniesta C; Tapia M; Cejas P; Machado-Pinilla R; Manguan-García C; Sánchez-Pérez I; Nistal M; Moratilla C; de Castro-Carpeño J; Gonzalez-Barón M; Albanell J; Perona R
Cancer Lett; 2009 Dec; 286(2):206-16. PubMed ID: 19553005
[TBL] [Abstract][Full Text] [Related]
51. SIRT3 functions as a tumor suppressor in hepatocellular carcinoma.
Zeng X; Wang N; Zhai H; Wang R; Wu J; Pu W
Tumour Biol; 2017 Mar; 39(3):1010428317691178. PubMed ID: 28347248
[TBL] [Abstract][Full Text] [Related]
52. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
[TBL] [Abstract][Full Text] [Related]
53. Placenta-specific protein 1 promotes cell proliferation and invasion in non-small cell lung cancer.
Yang L; Zha TQ; He X; Chen L; Zhu Q; Wu WB; Nie FQ; Wang Q; Zang CS; Zhang ML; He J; Li W; Jiang W; Lu KH
Oncol Rep; 2018 Jan; 39(1):53-60. PubMed ID: 29138842
[TBL] [Abstract][Full Text] [Related]
54. Minnelide/Triptolide Impairs Mitochondrial Function by Regulating SIRT3 in P53-Dependent Manner in Non-Small Cell Lung Cancer.
Kumar A; Corey C; Scott I; Shiva S; D'Cunha J
PLoS One; 2016; 11(8):e0160783. PubMed ID: 27501149
[TBL] [Abstract][Full Text] [Related]
55. Pituitary tumor transforming gene-1 in non-small cell lung cancer: Clinicopathological and immunohistochemical analysis.
Wang F; Liu Y; Chen Y
Biomed Pharmacother; 2016 Dec; 84():1595-1600. PubMed ID: 27829547
[TBL] [Abstract][Full Text] [Related]
56. Effects of downregulation of SIRT3 expression on proliferation and apoptosis in esophageal squamous cell carcinoma EC9706 cells and its molecular mechanisms.
Yang M; Yang C; Pei Y
Biomed Mater Eng; 2014; 24(6):3883-90. PubMed ID: 25227106
[TBL] [Abstract][Full Text] [Related]
57. Favorable prognosis of operable non-small cell lung cancer (NSCLC) patients harboring an increased expression of tumor endothelial markers (TEMs).
Pircher A; Fiegl M; Untergasser G; Heidegger I; Medinger M; Kern J; Hilbe W
Lung Cancer; 2013 Aug; 81(2):252-8. PubMed ID: 23664449
[TBL] [Abstract][Full Text] [Related]
58. Activated cdc42-associated kinase is up-regulated in non-small-cell lung cancer and necessary for FGFR-mediated AKT activation.
Hu F; Liu H; Xie X; Mei J; Wang M
Mol Carcinog; 2016 May; 55(5):853-63. PubMed ID: 25945695
[TBL] [Abstract][Full Text] [Related]
59. Wnt5a expression is associated with the tumor proliferation and the stromal vascular endothelial growth factor--an expression in non-small-cell lung cancer.
Huang CL; Liu D; Nakano J; Ishikawa S; Kontani K; Yokomise H; Ueno M
J Clin Oncol; 2005 Dec; 23(34):8765-73. PubMed ID: 16314637
[TBL] [Abstract][Full Text] [Related]
60. VASH2 Promotes Cell Proliferation and Resistance to Doxorubicin in Non-Small Cell Lung Cancer via AKT Signaling.
Tan X; Liao Z; Zou S; Ma L; Wang A
Oncol Res; 2020 Feb; 28(1):3-11. PubMed ID: 30940294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
